AKYNZEO CAPSULES 300MG/0.5MG
Product details
Registration number: SIN15031P
Classification: Prescription Only
Active ingredients:
- Netupitant
- Palonosetron HCl 0.56mg eqv to Palonosetron
Strength:
- 300mg
- 0.50mg
Dosage form: CAPSULE, GELATIN COATED
Route: ORAL
Registrant: JUNIPER HEALTHCARE PTE LTD
ATC code: A04AA55
HSA approval date: 8 June 2016
Manufacturer(s):
- Helsinn Birex Pharmaceuticals Ltd. (Intermediate Netupitant Tablets and final drug product)
- CATALENT PHARMA SOLUTIONS LLC (Intermediate Palonosetron softgels)
Manufacturing country/countries: UNITED STATES; IRELAND
What are the HSA registration number and classification for AKYNZEO CAPSULES 300MG/0.5MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15031P
Classification: Prescription Only
What active ingredients and strength are recorded for AKYNZEO CAPSULES 300MG/0.5MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Netupitant
- Palonosetron HCl 0.56mg eqv to Palonosetron
Strength:
- 300mg
- 0.50mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for AKYNZEO CAPSULES 300MG/0.5MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE, GELATIN COATED
Route: ORAL
Who is the recorded registrant for AKYNZEO CAPSULES 300MG/0.5MG?
According to the HSA dataset updated 7 August 2026:
Registrant: JUNIPER HEALTHCARE PTE LTD
Which manufacturers and countries are listed for AKYNZEO CAPSULES 300MG/0.5MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Helsinn Birex Pharmaceuticals Ltd. (Intermediate Netupitant Tablets and final drug product)
- CATALENT PHARMA SOLUTIONS LLC (Intermediate Palonosetron softgels)
Manufacturing country/countries: UNITED STATES; IRELAND
Where can I look up AKYNZEO CAPSULES 300MG/0.5MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15031P or the exact product name AKYNZEO CAPSULES 300MG/0.5MG. The general register link does not preselect this product.
What are the source dates for this AKYNZEO CAPSULES 300MG/0.5MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this AKYNZEO CAPSULES 300MG/0.5MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15031P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)